2009 | Reactive Oxygen Species Might Have Important Roles On Angiogenesis of Endothelial Progenitor Cells Derived From HCB(Human Cord Blood) Which Are Stimulated by VEGF. | 성주명; 유은선; 이경은; 문영철; 남은미 | Meeting Abstract |
2023 | Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation | 문영철 | Article |
2022 | Real-World Outcomes of Ruxolitinib in Patients With Myelofibrosis Focusing on Red Blood Cell Transfusion: A Multicenter Study From the MPN Working Party of the Korean Society of Hematology | 문영철 | Article |
2011 | Reduced-intensity conditioning allogeneic stem cell transplantation in the patients with acute leukemia | 김현경 | Master's Thesis |
2020 | Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia | 문영철 | Article |
2022 | Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma | 문영철 | Article |
2007 | Restoration of peroxiredoxins and catalase is closely correlated with the level of Philadelphia chromosome during imatinib therapy in CML | 성주명; 이서구; 유은선; 허정원; 이경은; 문영철; 우현애 | Meeting Abstract |
2013 | RESTORATION OF REDOX ENZYMES IS CORRELATED WITH REDUCTION OF BCR-ABL PROTEIN IN PHILADELPHIA POSITIVE CELLS DURING IMATINIB THERAPY | 성주명; 유은선; 허정원; 문영철 | Meeting Abstract |
2012 | Ring Chromosome 5 in acute myeloid leukemia defned by whole-genome single nucleotide polymorphism array | 정화순; 성주명; 허정원; 문영철 | Article |
2021 | Risk factors for neutropenic fever in non-Hodgkin's lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis | 문영철 | Article |
2008 | Risk factors of radiation pneumonitis in lung cancer | 성주명; 이경은; 문영철 | Meeting Abstract |
2018 | Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma | 문영철 | Article |
2012 | Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Chemotherapy Followed by High-Dose Therapy with ASCT for Newly Diagnosed Multiple Myeloma; Open-Labeled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis. | 문영철 | Meeting Abstract |
2011 | Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Induction Chemotherapy Followed by High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma; Open-Labelled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis | 문영철 | Meeting Abstract |
2022 | Serum biomarkers for bisphosphonate-related osteonecrosis of the jaw: a prospective clinical study | 문영철; 김선종; 김진우; 정태동; 박정현 | Article |
2005 | Signaling mechanisms of anti-proliferation by sphingosine 1-phoshate (S1P) on acute promyelocytic leukaemia cell lines | 성주명; 문영철 | Meeting Abstract |
2013 | Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality | 정화순; 성주명; 허정원; 문영철 | Article |
2011 | Single nucleotide polymorphism array-based karyotyping shows sequential genomic changes from monosomy to copy-neutral loss of heterozygosity of chromosome 7 and 20q deletion within a balanced translocation t(14;20) in AML | 정화순; 성주명; 허정원; 문영철 | Article |
2019 | Somatic mutation of HLA-DRB1*04:03 in a patient with myelodysplastic syndrome at diagnosis | 허정원; 문영철; 정태동; 박설희 | Article |
2015 | Submicroscopic Deletions of Immunoglobulin Heavy Chain Gene (IGH) in Precursor B Lymphoblastic Leukemia with IGH Rearrangements | 정화순; 성주명; 유은선; 허정원; 문영철 | Article |
2014 | Success rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in Korea. | 문영철 | Article |
2022 | Suppressive effect of α-mangostin for cancer stem cells in colorectal cancer via the Notch pathway | 정성애; 문영철; 김성은; 문창모; 김민석; 안영호 | Article |
2021 | The 2020 revision of the guidelines for the management of myeloproliferative neoplasms | 문영철 | Review |
2016 | The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea | 문영철 | Article |
2007 | The clinical outcomes of autologous stem cell transplantation in peripheral T cell lymphoma: From retrospective Multicenter study in Korea. | 문영철 | Meeting Abstract |
2018 | The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma | 문영철 | Article |
2020 | The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study) | 문영철 | Article |
2007 | The equal activity of azacytidine in 4 risk groups of IPSS in MDS | 문영철 | Meeting Abstract |
2006 | The intention to treat analysis of the different post remission therapy modalities in AML patients with the "Intermediate Risk Group (IPG)" based on cytogenetics. | 성주명; 문영철 | Meeting Abstract |
2007 | The intention to treat analysis of the different post-remission therapy modalities in AML patients with the Intermediate Risk Group based on cytogenetics | 문영철 | Meeting Abstract |